Beneficial impact of intracerebroventricular fractalkine administration on behavioral and biochemical changes induced by prenatal stress in adult rats: Possible role of NLRP3 inflammasome pathway

Biochemical Pharmacology

Volumn 113, Issue , 2016, Pages 45-56

  Ślusarczyk, Joanna ^a   Trojan, Ewa ^a   Wydra, Karolina ^a   Głombik, Katarzyna ^a   Chamera, Katarzyna ^a   Kucharczyk, Mateusz ^a,b   Budziszewska, Bogusława ^a   Kubera, Marta ^a   Lasoń, Władysław ^a   Filip, Małgorzata ^a   Basta Kaim, Agnieszka ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Brain; Fractalkine (CX3CL1); Inflammation; NLRP3 inflammasome; Prenatal stress

Indexed keywords

CRYOPYRIN; FRACTALKINE; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; MESSENGER RNA; NLRP3 PROTEIN, RAT;

ADULT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOCHEMICAL ANALYSIS; CONTROLLED STUDY; DRUG EFFECT; FRONTAL CORTEX; HIPPOCAMPUS; MALE; NONHUMAN; PRENATAL STRESS; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; ANIMAL; COMPLICATION; DRUG EFFECTS; FEMALE; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MENTAL STRESS; METABOLISM; PREGNANCY; PRENATAL EXPOSURE; PSYCHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BEHAVIOR, ANIMAL; CHEMOKINE CX3CL1; CYTOKINES; FEMALE; HIPPOCAMPUS; INFLAMMASOMES; INJECTIONS, INTRAVENTRICULAR; MALE; NLR FAMILY, PYRIN DOMAIN-CONTAINING 3 PROTEIN; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SIGNAL TRANSDUCTION; STRESS, PSYCHOLOGICAL;

EID: 84973863196     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2016.05.008     Document Type: Article

References (61)

1. [1] Wichers, M.C., Kenis, G., Leue, C., Koek, G., Robaeys, G., Maes, M., Baseline immune activation as a risk factor for the onset of depression during interferon-alpha treatment. Biol. Psychiatry 60 (2006), 77–79.
2. [2] Kubera, M., Obuchowicz, E., Goehler, L., Brzeszcz, J., Maes, M., In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 35 (2011), 744–759.
3. [3] Réus, G.Z., Fries, G.R., Stertz, L., Badawy, M., Passos, I.C., Barichello, T., Kapczinski, F., Quevedo, J., The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders. Neuroscience 300 (2015), 141–154.
4. [4] Goldsmith, D.R., Rapaport, M.H., Miller, B.J., A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol. Psychiatry, 2016, 10.1038/mp.2016.3.
5. [5] Money, K.M., Olah, Z., Korade, Z., Garbett, K.A., Shelton, R.C., Mirnics, K., An altered peripheral IL6 response in major depressive disorder. Neurobiol. Dis. 89 (2016), 46–54.
6. [6] Wang, T.Y., Lee, S.Y., Chen, S.L., Chung, Y.L., Li, C.L., Chang, Y.H., Wang, L.J., Chen, P.S., Chen, S.H., Chu, C.H., Huang, S.Y., Tzeng, N.S., Hsieh, T.H., Chiu, Y.C., Lee, I.H., Chen, K.C., Yang, Y.K., Hong, J.S., Lu, R.B., The differential levels of inflammatory cytokines and BDNF among bipolar spectrum disorders. Int. J. Neuropsychopharmacol., 2016.
7. [7] Diz-Chaves, Y., Pernía, O., Carrero, P., Garcia-Segura, L.M., Prenatal stress causes alterations in the morphology of microglia and the inflammatory response of the hippocampus of adult female mice. J. Neuroinflamm. 9 (2012), 1–10.
8. [8] Xiu, L.J., Lin, H.M., Wei, P.K., The effect of chronic mild stress on tumor-bearing rats’ behavior and its mechanism. Neurosci. Lett. 473 (2010), 1–4.
9. [9] Szczesny, E., Basta-Kaim, A., Slusarczyk, J., Trojan, E., Glombik, K., Regulska, M., Leskiewicz, M., Budziszewska, B., Kubera, M., Lason, W., The impact of prenatal stress on insulin-like growth factor-1 and pro-inflammatory cytokine expression in the brains of adult male rats: the possible role of suppressors of cytokine signaling proteins. J. Neuroimmunol. 276 (2014), 37–46.
10. [10] Stachowicz, A., Głombik, K., Olszanecki, R., Basta-Kaim, A., Suski, M., Lasoń, W., Korbut, R., The impact of mitochondrial aldehyde dehydrogenase (ALDH2) activation by Alda-1 on the behavioral and biochemical disturbances in animal model of depression. Brain Behav. Immun. 51 (2016), 144–153.
11. [11] Diz-Chaves, Y., Astiz, M., Bellini, M.J., Garcia-Segura, L.M., Prenatal stress increases the expression of proinflammatory cytokines and exacerbates the inflammatory response to LPS in the hippocampal formation of adult male mice. Brain Behav. Immun. 28 (2013), 196–206.
12. [12] Sheridan, G.K., Murphy, K.J., Neuron-glia crosstalk in health and disease: fractalkine and CX3CR1 take centre stage. Open Biol. 3 (2013), 1–14.
13. [13] Limatola, C., Ransohoff, R.M., Modulating neurotoxicity through CX3CL1/CX3CR1 signaling. Front. Cell. Neurosci. 8 (2014), 1–8.
14. [14] Arnoux, I., Audinat, E., Fractalkine signaling and microglia functions in the developing brain. Neural. Plast., 2015, 2015, 689404.
15. [15] Wolf, Y., Yona, S., Kim, K.W., Jung, S., Microglia, seen from the CX3CR1 angle. Front. Cell. Neurosci. 7 (2013), 1–9.
16. [16] Bazan, J.F., Bacon, K.B., Hardiman, G., Wang, W., Soo, K., Rossi, D., Greaves, D.R., Zlotnik, A., Schall, T.J., A new class of membrane-bound chemokine with a CX3C motif. Nature 385 (1997), 640–644.
17. [17] Chen, S., Luo, D., Streit, W.J., Harrison, J.K., TGF-beta1 upregulates CX3CR1 expression and inhibits fractalkine-stimulated signaling in rat microglia. J. Neuroimmunol. 133 (2002), 46–55.
18. [18] Corona, A.W., Huang, Y., O'Connor, J.C., Dantzer, R., Kelley, K.W., Popovich, P.G., Godbout, J.P., Fractalkine receptor (CX3CR1) deficiency sensitizes mice to the behavioral changes induced by lipopolysaccharide. J. Neuroinflamm. 17 (2010), 1–14.
19. [19] Milior, G., Lecours, C., Samson, L., Bisht, K., Poggini, S., Pagani, F., Deflorio, C., Lauro, C., Alboni, S., Limatola, C., Branchi, I., Tremblay, M.E., Maggi, L., Fractalkine receptor deficiency impairs microglial and neuronal responsiveness to chronic stress. Brain Behav. Immun., 2015 pii: S0889-1591(15)00419-5.
20. [20] Zujovic, V., Benavides, J., Vigé, X., Carter, C., Taupin, V., Fractalkine modulates TNF-alpha secretion and neurotoxicity induced by microglial activation. Glia 29 (2000), 305–315.
21. [21] Mizuno, T., Kawanokuchi, J., Numata, K., Suzumura, A., Production and neuroprotective functions of fractalkine in the central nervous system. Brain Res. 979 (2003), 65–70.
22. [22] Zujovic, V., Schussler, N., Jourdain, D., Duverger, D., Taupin, V., In vivo neutralization of endogenous brain fractalkine increases hippocampal TNFalpha and 8-isoprostane production induced by intracerebroventricular injection of LPS. J. Neuroimmunol. 115 (2001), 135–143.
23. [23] Rogers, J.T., Morganti, J.M., Bachstetter, A.D., Hudson, C.E., Peters, M.M., Grimmig, B.A., Weeber, E.J., Bickford, P.C., Gemma, C., CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity. J. Neurosci. 31 (2011), 1–24.
24. [24] Corona, A.W., Norden, D.M., Skendelas, J.P., Huang, Y., O'Connor, J.C., Lawson, M., Dantzer, R., Kelley, K.W., Godbout, J.P., Indoleamine 2,3-dioxygenase inhibition attenuates lipopolysaccharide induced persistent microglial activation and depressive-like complications in fractalkine receptor (CX(3)CR1)-deficient mice. Brain Behav. Immun. 31 (2013), 1–22.
25. [25] Hellwig, S., Brioschi, S., Dieni, S., Frings, L., Masuch, A., Blank, T., Biber, K., Altered microglia morphology and higher resilience to stress-induced depression-like behavior in CX3CR1-deficient mice. Brain Behav. Immun., 2015, 2015 pii: S0889-1591(15)30052-0.
26. [26] Morley-Fletcher, S., Darnaudery, M., Koehl, M., Casolini, P., Van Reeth, O., Maccari, S., Prenatal stress in rats predicts immobility behavior in the forced swim test. Effects of a chronic treatment with tianeptine. Brain Res. 989 (2003), 246–251.
27. [27] Basta-Kaim, A., Szczesny, E., Glombik, K., Stachowicz, K., Slusarczyk, J., Nalepa, I., Zelek-Molik, A., Rafa-Zablocka, K., Budziszewska, B., Kubera, M., Leskiewicz, M., Lason, W., Prenatal stress affects insulin-like growth factor-1 (IGF-1) level and IGF-1 receptor phosphorylation in the brain of adult rats. Eur. Neuropsychopharmacol. 24 (2014), 1546–1556.
28. [28] Wydra, K., Golembowska, K., Zaniewska, M., Kamińska, K., Ferraro, L., Fuxe, K., Filip, M., Accumbal and pallidal dopamine, glutamate and GABA overflow during cocaine self-administration and its extinction in rats. Addict. Biol. 18 (2013), 307–324.
29. [29] Paxinos, G., Watson, C., The Rat Brain in Stereotaxic Coordinates. 1998, Academic Press, San Diego.
30. [30] Detke, M.J., Rickels, M., Lucki, I., Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 121 (1995), 66–72.
31. [31] Pellow, S., Chopin, P., File, S.E., Briley, M., Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods 14 (1985), 149–167.
32. [32] Basta-Kaim, A., Fijał, K., Ślusarczyk, J., Trojan, E., Głombik, K., Budziszewska, B., Leśkiewicz, M., Regulska, M., Kubera, M., Lasoń, W., Wędzony, K., Prenatal administration of lipopolysaccharide induces sex-dependent changes in glutamic acid decarboxylase and parvalbumin in the adult rat brain. Neuroscience 287 (2015), 78–92.
33. [33] Ennaceur, A., Delacour, J., A new one-trial test for neurobiological studies of memory in rats. 1. Behavioral data. Behav. Brain Res. 31 (1988), 47–59.
34. [34] Sugama, S., Takenouchi, T., Fujita, M., Kitani, H., Hashimoto, M., Cold stress induced morphological microglial activation and increased IL-1β expression in astroglial cells in rat brain. J. Neuroimmunol. 233 (2011), 29–36.
35. [35] Zhao, Q., Peng, C., Wu, X., Chen, Y., Wang, C., You, Z., Maternal sleep deprivation inhibits hippocampal neurogenesis associated with inflammatory response in young offspring rats. Neurobiol. Dis. 68 (2014), 57–65.
36. [36] Budziszewska, B., Szymanska, M., Leskiewicz, M., Basta-Kaim, A., Jaworska-Feil, L., Kubera, M., Jantas, D., Lason, W., The decrease in JNK- and p38-MAP kinase activity is accompanied by the enhancement of PP2A phosphate level in the brain of prenatally stressed rats. J. Physiol. Pharmacol. 61 (2010), 207–215.
37. [37] Głombik, K., Stachowicz, A., Ślusarczyk, J., Trojan, E., Budziszewska, B., Suski, M., Kubera, M., Lasoń, W., Wędzony, K., Olszanecki, R., Basta-Kaim, A., Maternal stress predicts altered biogenesis and the profile of mitochondrial proteins in the frontal cortex and hippocampus of adult offspring rats. Psychoneuroendocrinology 60 (2015), 151–162.
38. [38] Cardona, A.E., Pioro, E.P., Sasse, M.E., Kostenko, V., Cardona, S.M., Dijkstra, I.M., Huang, D., Kidd, G., Dombrowski, S., Dutta, R., Lee, J.C., Cook, D.N., Jung, S., Lira, S.A., Littman, D.R., Ransohoff, R.M., Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci. 9 (2006), 917–924.
39. [39] Frick, L.R., Williams, K., Pittenger, C., Microglial dysregulation in psychiatric disease. Clin. Dev. Immunol., 2013, 2013, 608654.
40. [40] Paolicelli, R.C., Bisht, K., Tremblay, M.È., Fractalkine regulation of microglial physiology and consequences on the brain and behavior. Front. Cell. Neurosci. 8 (2014), 1–10.
41. [41] Bollinger, J.L., Bergeon Burns, C.M., Wellman, C.L., Differential effects of stress on microglial cell activation in male and female medial prefrontal cortex. Brain Behav. Immun. 52 (2016), 88–97.
42. [42] Lyons, A., Lynch, A.M., Downer, E.J., Hanley, R., O'Sullivan, J.B., Smith, A., Lynch, M.A., Fractalkine-induced activation of the phosphatidylinositol-3 kinase pathway attenuates microglial activation in vivo and in vitro. J. Neurochem. 110 (2009), 1547–1556.
43. [43] Bachstetter, A.D., Morganti, J.M., Jernberg, J., Schlunk, A., Mitchell, S.H., Brewster, K.W., Hudson, C.E., Cole, M.J., Harrison, J.K., Bickford, P.C., Gemma, C., Fractalkine and CX3CR1 regulate hippocampal neurogenesis in adult and aged rats. Neurobiol. Aging 32 (2011), 1–26.
44. [44] Kierdorf, K., Prinz, M., Factors regulating microglia activation. Front. Cell. Neurosci. 7 (2013), 1–8.
45. [45] Zhang, S., Wang, X.J., Tian, L.P., Pan, J., Lu, G.Q., Zhang, Y.J., Ding, J.Q., Chen, S.D., CD200-CD200R dysfunction exacerbates microglial activation and dopaminergic neurodegeneration in a rat model of Parkinson's disease. J. Neuroinflamm. 8 (2014), 1–12.
46. [46] Qin, W., Li, Z., Luo, S., Wu, R., Pei, Z., Huang, R., Exogenous fractalkine enhances proliferation of endothelial cells, promotes migration of endothelial progenitor cells and improves neurological deficits in a rat model of ischemic stroke. Neurosci. Lett. 21 (2014), 80–84.
47. [47] Pabon, M.M., Bachstetter, A.D., Hudson, C.E., Gemma, C., Bickford, P.C., CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease. J. Neuroinflamm. 8 (2011), 1–7.
48. [48] Choi, J.H., Won, M.H., Microglia in the normally aged hippocampus. Lab. Anim. Res. 27 (2011), 181–187.
49. [49] Majumder, S., Zhou, L.Z., Chaturvedi, P., Babcock, G., Aras, S., Ransohoff, R.M., Regulation of human IP-10 gene expression in astrocytoma cells by inflammatory cytokines. J. Neurosci. Res. 54 (1998), 169–180.
50. [50] Liu, D., Wang, Z., Liu, S., Wang, F., Zhao, S., Hao, A., Anti-inflammatory effects of fluoxetine in lipopolysaccharide(LPS)-stimulated microglial cells. Neuropharmacology 61 (2011), 592–599.
51. [51] Lee, M., Neurotransmitters and microglial-mediated neuroinflammation. Curr. Protein Pept. Sci. 14 (2013), 21–32.
52. [52] Felger, J.C., Lotrich, F.E., Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications. Neuroscience 246 (2013), 1–55.
53. [53] Weerasinghe, G.R., Rapoport, S.I., Bosetti, F., The effect of chronic lithium on arachidonic acid release and metabolism in rat brain does not involve secretory phospholipase A2 or lipoxygenase/cytochrome P450 pathways. Brain Res. Bull. 63 (2004), 485–489.
54. [54] Frank, M.G., Hershman, S.A., Weber, M.D., Watkins, L.R., Maier, S.F., Chronic exposure to exogenous glucocorticoids primes microglia to pro-inflammatory stimuli and induces NLRP3 mRNA in the hippocampus. Psychoneuroendocrinology 40 (2014), 191–200.
55. [55] Pan, Y., Chen, X.Y., Zhang, Q.Y., Kong, L.D., Microglial NLRP3 inflammasome activation mediates IL-1β-related inflammation in prefrontal cortex of depressive rats. Brain Behav. Immun. 41 (2014), 90–100.
56. [56] Gustin, A., Kirchmeyer, M., Koncina, E., Felten, P., Losciuto, S., Heurtaux, T., Tardivel, A., Heuschling, P., Dostert, C., NLRP3 inflammasome is expressed and functional in mouse brain microglia but not in astrocytes. PLoS ONE, 10, 2015, e0130624.
57. [57] Alcocer-Gómez, E., Ulecia-Morón, C., Marín-Aguilar, F., Rybkina, T., Casas-Barquero, N., Ruiz-Cabello, J., Ryffel, B., Apetoh, L., Ghiringhelli, F., Bullón, P., Sánchez-Alcazar, J.A., Carrión, A.M., Cordero, M.D., Stress-induced depressive behaviors require a functional NLRP3 inflammasome. Mol. Neurobiol., 2015.
58. [58] Kim, H.K., Andreazza, A.C., Elmi, N., Chen, W., Young, L.T., Nod-like receptor pyrin containing 3 (NLRP3) in the post-mortem frontal cortex from patients with bipolar disorder: a potential mediator between mitochondria and immune-activation. J. Psychiatr. Res. 72 (2016), 43–50.
59. [59] Franchi, L., Eigenbrod, T., Muñoz-Planillo, R., Nuñez, G., The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat. Immunol. 10 (2009), 241–247.
60. [60] Sollberger, G., Strittmatter, G.E., Garstkiewicz, M., Sand, J., Beer, H.D., Caspase-1: the inflammasome and beyond. Innate Immun. 20 (2014), 115–125.
61. [61] Vanaja, S.K., Rathinam, V.A., Fitzgerald, K.A., Mechanisms of inflammasome activation: recent advances and novel insights. Trends Cell Biol. 25 (2015), 308–315.